MindBio Therapeutics Corp.
MBIO
CNSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.71M | -3.89M | -2.55M | -1.79M | -1.04M |
| Total Depreciation and Amortization | -56.80K | -56.80K | 1.00K | 1.00K | 57.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.32M | 2.97M | 1.91M | 1.08M | 786.40K |
| Change in Net Operating Assets | 350.70K | 265.90K | 341.50K | 387.50K | -7.00K |
| Cash from Operations | -1.09M | -706.90K | -296.50K | -322.80K | -202.90K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 6.40K | 6.40K | 6.40K | 6.40K | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 6.40K | 6.40K | 6.40K | 6.40K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.30K | -1.30K | -1.30K | -9.30K | -20.60K |
| Issuance of Common Stock | 1.79M | 1.44M | 440.40K | 440.40K | 165.00K |
| Repurchase of Common Stock | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -400.00 | -400.00 | -400.00 | -400.00 | 0.00 |
| Cash from Financing | 1.18M | 938.80K | 282.90K | 277.50K | 93.80K |
| Foreign Exchange rate Adjustments | -67.00K | -10.50K | -10.50K | -10.50K | -42.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23.80K | 227.70K | -17.70K | -49.30K | -151.50K |